← Back to Search

Procedure

Geniculate Artery Embolization arm for Osteoarthritis

N/A

Recruiting

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient not a surgical candidate or declines surgical management

Age > 40 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1, 3 and 6 months

Awards & highlights

Study Summary

This trial will test the effectiveness of GAE in reducing knee pain in patients with OA. Osteoarthritis is a degenerative joint disease that can cause pain & disability, especially in older Canadians. This trial will test a minimally invasive alternative treatment to reduce knee pain.

Who is the study for?

This trial is for individuals over 40 with knee osteoarthritis who haven't found relief from pain after at least 3 months of conservative treatments, such as medication or injections. It's aimed at those who are not candidates for surgery or choose not to undergo it.Check my eligibility

What is being tested?

The trial is testing Geniculate Artery Embolization (GAE), a minimally invasive procedure designed to reduce inflammation and pain in the knee by disrupting blood vessel growth and nerve fiber development associated with osteoarthritis.See study design

What are the potential side effects?

While GAE has a low risk of complications, potential side effects may include minor bruising or soreness at the catheter insertion site, temporary numbness, allergic reaction to contrast materials used during the procedure, and rare cases of infection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I cannot or choose not to have surgery for my condition.

Select...

I am over 40 years old.

Select...

My X-rays show arthritis in the knee that hurts.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1, 3 and 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1, 3 and 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 3 and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Pain Reduction

Pain medication required

Pain, stiffness and physical function

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Geniculate Artery Embolization armExperimental Treatment1 Intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Geniculate Artery Embolization

2018

N/A

~50

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor

792 Previous Clinical Trials

869,104 Total Patients Enrolled

14 Trials studying Osteoarthritis

1,014 Patients Enrolled for Osteoarthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the study open to enrolling new participants at this time?

"According to clinicaltrials.gov, the recruitment for this trial is still ongoing. It was initially publicized on January 1st 2023 and recently revised on May 9th 2023."

Answered by AI

What is the upper limit of participants for this research initiative?

"Affirmative. The information on clinicaltrials.gov suggests that this study is currently open for recruitment, having been initially posted on 1/1/2023 and most recently edited on 5/9/2023. A total of 50 participants are sought from a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Geniculate Artery Embolization for the Treatment of Knee Osteoarthritis

2023. "Geniculate Artery Embolization for the Treatment of Knee Osteoarthritis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05386797.

All > Knee Osteoarthritis